In October, the U.S. Food and Drug Administration (FDA) released the
We’ve repeatedly commented on the awkward interface between the cannabinoid industry and the FDA. The agency is compelled to act given the political noise than cannabis makes, especially CBD in the past couple of years. The passage of the 2018 Farm Bill increased pressure on the agency to act on CBD regulation, but the agency is accustomed to stakeholders operating within well-defined clinical research parameters.
In addition to proposed legislation meant to circumvent the agency on CBD regulation, Former leader McConnell’s (R-KY) congress required the agency to update…
01.09.2025
Additional 45z guidance expected on January 10
Information addressing the Bipartisan Infrastructure Law (BIL) and the Inflation Reduction Act (IRA) is expected to be released on Friday January 10, according to several sources speaking with...
01.09.2025
Prices for US animal fats and oils unchanged; market tightness persists
The US animal fats and oils markets were unchanged on Thursday January 9, as trade slowed following an active start to the week.
Participants continued to report stable pricing in...
01.09.2025
Averted ILA port strike eases animal protein market tension; November dog, cat food exports rise
US animal protein prices were steady on Thursday January 9. With the International Longshoremen’s Association (ILA) port strike avoided, sources expect unease to diminish to a degree. However, trade...